View this email in your browser

Quarterly Newsletter

Winter 2017

The ODPRN Quarterly Newsletters have a new look and will feature important research, news and opportunities related to drug policy in Ontario. Be sure to update your subscription preferences to also receive our new research e-alerts!

Recently Released

Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada
An estimated $30.3 million in annual savings across 8 provinces through the implementation of a blood glucose test strip quantity limit.

High-Dose Opioid Prescribing and Opioid-Related Hospitalization
This study investigates whether national clinical practice guidelines released in 2010 and provincial drug policy legislation implemented in 2011 impacted the prevalence of high-dose opioid prescribing and rates of hospital visits for opioid toxicity in Ontario.

ODPRN in the News

Opioid prescribing down, but OD-related hospital visits continue to climb: study
Medically sanctioned opioid use has dropped by almost 14 per cent since national guidelines for prescribing the drugs were introduced in 2010, yet the rate of overdose-related hospital visits continued to rise, an Ontario study has found.

Canadian children now take far more mood-altering drugs, prescription count shows
Canadian doctors are increasingly medicating children with antidepressants and antipsychotics, suggests a new study experts worry is the latest sign of using drugs to achieve “behavioural control.”

Student and Career Opportunities

We are now accepting applications for a summer student opportunity starting May 2017! The ODPRN Student Training Program is seeking a motivated and hard-working Master’s or undergraduate (including medicine and pharmacy) summer student with a strong interest in drug policy research.

Apply here by March 1, 2017.

ODPRN Citizens' Panel

The ODPRN Citizens’ Panel is a group of 22 volunteer citizens from across Ontario who have collectively come together to ensure that the ODPRN appropriately identifies issues of importance to the public, and incorporates these priorities into all aspects of our research. Learn more about who they are and what they do.

Interested in becoming a member? Please email Dana Bandola (bandolad@smh.ca) to find out how to apply or for more information.

Sneak Peek: Upcoming Research

Opioid-Related Deaths in Ontario
The rate of opioid prescribing and number of deaths related to opioid overdoses have increased dramatically over the last two decades in Ontario. We will be using newly accessible data from the Narcotic Monitoring System to understand the overall trends in opioid overdose and death.

Other News Related to Drug Policy in Ontario

2017 Draft Recommendations for Use of Opioids in Chronic Non-Cancer Pain
Michael G. DeGroote National Pain Centre | January 30, 2017

Canada’s Health Expenditure: Spending on Prescribed Drugs Increases, Total Growth Remains Slow
Canadian Institute for Health Information | December 15, 2016

The New Canadian Drugs and Substances Strategy
Government of Canada | December 12, 2016

Update Regarding Palliative Care Access to High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program
Ministry of Health and Long-Term Care | November 30, 2016

2016 National Opioid Conference
Government of Canada | November 18, 2016

Connect

Learn More

Copyright © 2016 ODPRN, All rights reserved.

St. Michael's Hospital, 30 Bond Street
Toronto, ON M5B 1W8, Canada

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

This email was sent to <<Email Address>>
why did I get this? unsubscribe from this list update subscription preferences
Ontario Drug Policy Research Network · St. Michael's Hospital c/o Applied Health Research Centre · 30 Bond St. · Toronto, On M5B 1W8 · Canada